Zobrazeno 1 - 10
of 13
pro vyhledávání: '"P. H. Blakemore"'
Publikováno v:
The Journal of antimicrobial chemotherapy. 31(6)
A clinical isolate of Shigella dysenteriae from Kashmir, resistant to seven antibacterial agents including nalidixic acid, carried four plasmids, only one of which was transferable by conjugation. This plasmid, designated pYD1, conferred trimethoprim
Autor:
P. H. Blakemore, Y. J. Drabu
Publikováno v:
The Journal of antimicrobial chemotherapy. 27
The post-antibiotic effect (PAE) of teicoplanin was measured alone and in combination with other antibiotics against Staphylococcus aureus. A total of five strains were used: the Oxford S. aureus and two clinical isolates each of methicillin sensitiv
Publikováno v:
The Journal of antimicrobial chemotherapy. 25(6)
One hundred and fifty Gram-negative bacterial strains including respiratory pathogens, such as Haemophilus influenzae and Branhamella catarrhalis, and Enterobacteriaceae with known resistance to beta-lactam and other antibiotics were tested in vitro
Autor:
Y J, Drabu, P H, Blakemore
Publikováno v:
Drugs under experimental and clinical research. 16(11)
The post-antibiotic effect (PAE) is the persistent suppression of bacterial growth after a short antibiotic exposure. It is well documented with a variety of antibiotics and micro-organisms and may have important therapeutic implications. The authors
Publikováno v:
Journal of Antimicrobial Chemotherapy. 21:89-92
Serious infections by methicillin-resistant staphylococci, 26 caused by Staphylococcus aureus and two by coagulase-negative staphylococci, were treated with teicoplanin 200-800 mg daily, in eight cases supplemented with another antibiotic. The overal
Publikováno v:
Journal of Antimicrobial Chemotherapy. 21:675-677
Publikováno v:
Journal of Antimicrobial Chemotherapy. 24:615-617
Publikováno v:
The Journal of antimicrobial chemotherapy. 23(2)
Publikováno v:
Drugs under experimental and clinical research. 14(10)
Carumonam is a new N-sulfo-beta-lactam antibiotic active against aerobic Gram-negative bacteria. An open study was carried out to evaluate the efficacy, safety and tolerance of carumonam with either 1 g t.i.d. (group A) or 2 g t.i.d. (group B) in bac